Brian Park, PharmD

Drug Information Specialist https://www.clinicaladvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Pediatrics Information Center

Moderna COVID-19 Vaccine Shows Robust Antibody Responses in Young Children

Brian Park, PharmD

March 25, 2022

The KidCOVE study is currently evaluating the immunogenicity, safety, and tolerability of the mRNA-1273 vaccine in healthy children.

Infectious Diseases Information Center

Reports of Injuries Prompt FDA Alert on Proper At-Home COVID-19 Test Use

Brian Park, PharmD

March 25, 2022

The incorrect use of these tests may cause harm if, for instance, the liquid solution comes in contact with the skin, nose, mouth, or eyes, or if it is swallowed.

Pain Information Center

Novel Sciatica Treatment Provides Significant Pain Relief in Phase 3 Trial

Brian Park, PharmD

March 24, 2022

SP-102 is a dexamethasone sodium phosphate viscous gel formulation that is administered by epidural injection.

Infectious Diseases Information Center

Moderna Seeks Authorization for Second COVID-19 Booster Shot for Adults

Brian Park, PharmD

March 18, 2022

This submission comes shortly after Pfizer and BioNTech submitted an EUA request for an additional booster dose of their COVID-19 vaccine for adults 65 years of age and older.

Oncology Information Center

Niraparib With Abiraterone + Prednisone Improves Outcomes in HRR BM+ Metastatic Castration Resistant Prostate Cancer

Brian Park, PharmD

March 18, 2022

The phase 3 MAGNITUDE study assessed niraparib in combination with abiraterone acetate plus prednisone in patients with mCRPC with or without alterations in homologous recombination repair associated genes.